1st Quarter - Report
INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$42,005
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 21, 2017 | $42,005 | Replaced |
| 1st Quarter - Amendment | May 23, 2017 | $39,626 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBIN R LEVY New | — |
| ANNA KELLEY SIDOROWICZ New | — |
Veterans VET
DoD - CDMRP
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBIN R LEVY | — |
| ANNA KELLEY SIDOROWICZ | — |
Budget/Appropriations BUD
DoD Approrprations - CDMRP NIH Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBIN R LEVY | — |
| ANNA KELLEY SIDOROWICZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.